hotspot -WSS

hotspot

author：knowledge 2025-09-30 22:22:23 - browse：3

Duchenne muscular dystrophy is a devastating disease and, until very recently, was one without much hope. When Hawken Miller was diagnosed at age 5, the physician told his parents to enjoy the time they had with him, as there wouldn’t be much. Over 20 years later, Miller is a journalist and content strategist for CureDuchenne, an organization started by his mother when he was diagnosed, and new treatment is on the horizon.

Last month, the FDA approved a new gene therapy from Sarepta Therapeutics that will provide hope for many patients and families. The new drug, however, has its limitations — it’s only approved for children age 4-5, for example. Miller joined the podcast to discuss how this drug may change lives, what more needs to happen, and what his personal experience has been living with Duchenne.

“For the older boys, we’re running up against the clock a little bit with what we’re able to do and what we’re not able to do,” Miller said. “And if we’re able to try anything that could possibly help, I think most people would like the opportunity to do that.”

The conversation is based off his recent First Opinion, “The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： How Long Island became the ‘eugenics capital of the world’

hotspot

WSS

Apellis safety probe of eye disease drug centers on injection needle

Drug firms test therapies to halt Alzheimer’s before symptoms arise

As pharma fights Medicare drug negotiation, hospitals, docs silent

Vertex non

What AAP's gender

How Long Island became the ‘eugenics capital of the world’

focus

hotspot

focus

Continuity nursing helped my family in our darkest PICU moments

General Catalyst, Summa Health deal will turn on physician buy

Medical leaders decry Supreme Court decision on affirmative action

General Catalyst, Summa Health deal will turn on physician buy

New air purifier tech could be key to improving indoor air quality

In science, is the line between industry and academia shifting?

Anesthesiologist group: stop taking Ozempic before surgery

In science, is the line between industry and academia shifting?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

leisure time

How to make AI work for medicine

AstraZeneca challenges Medicare drug negotiation program

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Medicare drug price negotiation’s day in court

Apellis safety probe of eye disease drug centers on injection needle

Vertigo drug brings hope for rare neuron disorder, Niemann

focus

hotspot

hotspot

entertainment